Global In-Vitro Diagnostics Market Growth (Status and Outlook) 2025-2031

Global In-Vitro Diagnostics Market Growth (Status and Outlook) 2025-2031

The global In-Vitro Diagnostics market size is predicted to grow from US$ 68680 million in 2025 to US$ 89780 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.

LPI (LP Information)' newest research report, the “In-Vitro Diagnostics Industry Forecast” looks at past sales and reviews total world In-Vitro Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected In-Vitro Diagnostics sales for 2025 through 2031. With In-Vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In-Vitro Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global In-Vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In-Vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In-Vitro Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In-Vitro Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In-Vitro Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of In-Vitro Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other

Segmentation by Application:
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
JNJ
Sysmex
KHB
DaAn Gene
Leadman
BioSino
BSBE
Maccura

Please note: The report will take approximately 2 business days to prepare and deliver.